Biopharma Analyst Chen, along with Mitchell Epner, Senior Counsel Member of Kudman Trachten Aloe Posner, discuss the COVID patent infringement litigation between ABUS/Genevant/ROIV and MRNA on an Analyst/Industry conference call to be held on April 26 at 1 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABUS:
- Biotech Alert: Searches spiking for these stocks today
- Arbutus Biopharma Wins Favorable Ruling Against Moderna
- Arbutus ‘pleased’ with claim construction ruling in patent infringement suit
- Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
- Moderna could owe $1B-$3B in royalties, says Jefferies
